Browsing Category
Healthcare Industry News
2694 posts
ResMed (ASX: RMD) drops 8% as Astral recall clouds FY27 outlook
ResMed fell 8% as FY27 sales guidance missed expectations. Astral recall costs and slower growth now test the ASX: RMD valuation.
Doximity (NYSE: DOCS) shares surge 55% as clinical AI adoption transforms the earnings story despite weaker profit
Doximity shares surged after fiscal Q1 revenue beat expectations and clinical AI engagement accelerated, even though earnings, free cash flow and EBITDA declined. The reaction suggests investors are beginning to value Doximity less as a physician advertising platform and more as a potential clinical AI infrastructure company.
How does tooth decay start and what can you do before a small cavity becomes a painful dental problem?
Learn how tooth decay starts, why dental caries causes cavities, how fillings and root canals work, and the best ways to prevent painful tooth problems.
Can sleeping warm and getting enough rest help keep the common cold at bay?
Can better sleep help prevent the common cold? Learn how sleep affects immunity, why colds spread in winter and what really helps reduce infection risk.
How woven surgical dressings are made and why gauze, crepe bandages and lint still matter in wound care
Learn how woven surgical dressings are made and understand gauze, crepe bandages, lint, warp, weft, yarn count and other wound-care terms.
Prostatitis explained: What causes prostate inflammation, how symptoms differ and when treatment is needed
Learn what causes prostatitis, its symptoms, main types, diagnosis and treatment, including when prostate infection requires antibiotics or urgent care.
Rasna explained: What makes Alpinia officinarum rhizomes medicinally important in traditional medicine?
Discover Rasna or Alpinia officinarum, including its chemical constituents, morphology, traditional medicinal uses, substitutes and common synonyms.
ReNerve (ASX:RNV) gains Philippine marketing approval for NervAlign nerve-repair device
ReNerve Limited has secured Philippine marketing approval for the NervAlign Nerve Cuff, opening another sizeable Asia-Pacific market as attention shifts to distribution, hospital adoption and recurring sales.
P&G bets $3.8bn on Thorne as Gen Z reshapes the supplements category
Procter & Gamble is paying $3.8 billion for Thorne, a 5.6x return for L Catterton in three years. Whether P&G's Healthcare arm can absorb it is the test.
Koning Health secures MDSAP certification as Seattle and Richmond installations widen U.S. breast CT footprint
Koning Corporation is pairing a multi-market quality certification with new Koning Vera Breast CT installations, but wider adoption still depends on referrals, reimbursement and measurable clinical utilisation.